Li-Yuan Bai
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents 4
-
- Genomics, phytochemicals, and oxidative stress 5
- Histone Deacetylase Inhibitors Research 4
-
- NF-κB Signaling Pathways 4
- Ophthalmology top 10%
-
- Autophagy in Disease and Therapy 6
-
- Chronic Lymphocytic Leukemia Research 4
-
- Cancer-related Molecular Pathways 4
-
- Gastric Cancer Management and Outcomes 4
- Co-authors
- Chang-Fang ChiuJing‐Ru WengShih-Jiuan ChiuAaron M. SargeantPo‐Chen ChuChia-Yung WuMing-Hsui TsaiEn‐Chi Hsu
- Partner nations
- TaiwanUnited StatesEgypt
In The Last Decade
Li-Yuan Bai
41 papers receiving 851 citations
Peers
Comparison fields: 5 of 93
- Toxicology 36
- Molecular Biology 466
- Cancer Research 99
- Immunology and Allergy 39
- Ophthalmology 58
Countries citing papers authored by Li-Yuan Bai
This map shows the geographic impact of Li-Yuan Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li-Yuan Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li-Yuan Bai more than expected).
Fields of papers citing papers by Li-Yuan Bai
This network shows the impact of papers produced by Li-Yuan Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li-Yuan Bai. The network helps show where Li-Yuan Bai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li-Yuan Bai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2020 | 9 | |
| 5 | 2018 | 13 | |
| 6 | 2017 | 37 | |
| 7 | 2017 | 7 | |
| 8 | 2016 | 49 | |
| 9 | 2015 | 3 | |
| 10 | 2014 | 13 | |
| 11 | 2014 | 8 | |
| 12 | 2013 | 25 | |
| 13 | 2013 | 48 | |
| 14 | 2012 | 34 | |
| 15 | 2011 | 10 | |
| 16 | 2011 | 12 | |
| 17 | 2010 | 28 | |
| 18 | 2009 | 9 | |
| 19 | 2006 | 58 | |
| 20 | 2005 | 6 |
About Li-Yuan Bai
Li-Yuan Bai is a scholar working on Toxicology, Physiology and Genetics, having authored 42 papers that have together received 869 indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers), Bioactive Compounds and Antitumor Agents (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Cancer-related Molecular Pathways (4 papers), Gastric Cancer Management and Outcomes (4 papers) and NF-κB Signaling Pathways (4 papers). The work is most often cited by research in Toxicology (36 citations), Molecular Biology (466 citations) and Cancer Research (99 citations). Li-Yuan Bai has collaborated with scholars based in Taiwan, United States and Egypt. Frequent co-authors include Chang-Fang Chiu, Jing‐Ru Weng, Shih-Jiuan Chiu, Aaron M. Sargeant, Po‐Chen Chu, Chia-Yung Wu, Ming-Hsui Tsai, En‐Chi Hsu, Su-Peng Yeh and Ching-Shih Chen. Their work appears in journals such as Journal of Clinical Oncology, Blood and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.